Dana-Farber President and CEO Edward J. Benz, Jr, MD, to Retire in 2016


Get Permission

Edward J. Benz, Jr, MD

Dana-Farber President and CEO Edward J. Benz, Jr, MD, has announced he will retire from the Dana-Farber Cancer Institute (DFCI) in 2016, after 16 years running the organization.

Dr. Benz will also vacate the positions as Director and Principal Investigator of the Dana-Farber/Harvard Cancer Center and Trustee of Dana-Farber/Children’s Hospital Cancer Care.

He will remain Professor of Medicine, Pediatrics, and Genetics at Harvard Medical School and will focus full-time on his research.

Under Dr. Benz’s leadership, Dana-Farber has tripled in size. Annual giving has grown from $50 million to $200 million, and revenue has tripled to roughly $1.1 billion. Dana-Farber’s workforce and patient volume have also tripled in the interim. ■

 


Advertisement

Advertisement



Advertisement